FBT
CYTK icon

First Bank & Trust’s Cytokinetics CYTK Stock Holding History

First Bank & Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$545K Sell
6,392
-2
-0% -$144 0.08% 165
2026
Q1 		$421K Sell
6,394
-13
-0.2% -$826 0.07% 173
2025
Q4 		$407K Buy
6,407
+103
+2% +$6.41K 0.07% 181
2025
Q3 		$346K Hold
6,304
– – 0.06% 186
2025
Q2 		$208K Sell
6,304
-121
-2% -$4.21K 0.04% 226
2025
Q1 		$258K Hold
6,425
– – 0.05% 193
2024
Q4 		$302K Sell
6,425
-297
-4% -$15.4K 0.06% 181
2024
Q3 		$355K Sell
6,722
-35
-0.5% -$1.95K 0.07% 164
2024
Q2 		$366K Buy
6,757
+303
+5% +$18.3K 0.07% 153
2024
Q1 		$452K Buy
+6,454
New +$499K 0.09% 134

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Bank & Trust's CYTK Position: Q2 2026 in Review

First Bank & Trust reduced its Cytokinetics (CYTK) stake by 0.03% in Q2 2026, selling an estimated $144 and leaving 6,392 shares worth $545K. The position accounts for 0.08% of the portfolio, ranked #165.

First Bank & Trust first reported a position in CYTK in Q1 2024 and has held it in 10 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • First Bank & Trust held 6,392 shares of Cytokinetics worth $545K as of Q2 2026.
  • First Bank & Trust sold 2 Cytokinetics shares in Q2 2026, an estimated $144.
  • Cytokinetics made up 0.08% of First Bank & Trust's portfolio in Q2 2026, its #165 holding.
  • First Bank & Trust first reported a position in Cytokinetics in Q1 2024 and has held it in 10 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.